{"id":836037,"date":"2025-04-10T09:14:19","date_gmt":"2025-04-10T13:14:19","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-to-present-at-world-vaccine-congress\/"},"modified":"2025-04-10T09:14:19","modified_gmt":"2025-04-10T13:14:19","slug":"evaxion-to-present-at-world-vaccine-congress","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-to-present-at-world-vaccine-congress\/","title":{"rendered":"Evaxion to present at World Vaccine Congress"},"content":{"rendered":"<div class=\"mw_release\">\n<p \/>\n<ul>\n<li>\n          <b>Congress will take place April 21-24, 2025, in Washington, D.C.<br \/><\/b><br \/>\n          <b><\/b>\n        <\/li>\n<\/ul>\n<p align=\"justify\">COPENHAGEN, Denmark, April 10, 2025 &#8211; Evaxion Biotech A\/S (NASDAQ: EVAX) (\u201cEvaxion\u201d), a clinical-stage TechBio company specializing in developing AI-Immunology\u2122 powered vaccines, will give two presentations and man a booth at the World Vaccine Congress taking place April 21-24, 2025, in Washington, D.C.<\/p>\n<p align=\"justify\">Birgitte R\u00f8n\u00f8, Chief Scientific Officer at Evaxion, will talk about the application of Evaxion\u2019s AI-Immunology\u2122 platform for antigen target discovery for cancer vaccines. P\u00e4r Comstedt, Vice President, Infectious Disease Vaccine Development at Evaxion, will present the use of AI-Immunology\u2122 for target discovery for infectious disease vaccines. See details on the presentations below.<\/p>\n<p align=\"justify\">The World Vaccine Congress is just one of several scientific, partnering and investor conferences where Evaxion will profile itself and discuss with potential partners and collaborators in the second quarter of 2025.<\/p>\n<p align=\"justify\">Throughout the conference, Evaxion invites interested parties to its booth #351 for discussions on effective and accurate target discovery with AI-Immunology\u2122 as well as our pipeline of vaccine candidates for cancers and infectious diseases.<\/p>\n<p align=\"justify\">\n        <b>Presentation details:<\/b>\n      <\/p>\n<table border=\"1\" style=\"border-collapse: collapse;width: 100%;border-width: 0px;border-style: none;height: 91.969px\">\n<colgroup>\n<col style=\"width: 13.3731%\" \/>\n<col style=\"width: 86.6269%\" \/>\n        <\/colgroup>\n<tr style=\"height: 13.5938px\">\n<td style=\"height: 13.5938px;border-width: 0px\">Title:<\/td>\n<td style=\"height: 13.5938px;border-width: 0px\">AI-powered antigen target discovery for cancer vaccines<\/td>\n<\/tr>\n<tr style=\"height: 19.5938px\">\n<td style=\"height: 19.5938px;border-width: 0px\">Category:<\/td>\n<td style=\"height: 19.5938px;border-width: 0px\">Cancer immunotherapy<\/td>\n<\/tr>\n<tr style=\"height: 19.5938px\">\n<td style=\"height: 19.5938px;border-width: 0px\">Location:<\/td>\n<td style=\"height: 19.5938px;border-width: 0px\">Room 206<\/td>\n<\/tr>\n<tr style=\"height: 19.5938px\">\n<td style=\"height: 19.5938px;border-width: 0px\">Date\/Time:<\/td>\n<td style=\"height: 19.5938px;border-width: 0px\">April 23, 2025, at 11.40 ET\/17.40 CET \u00a0\u00a0<\/td>\n<\/tr>\n<tr style=\"height: 19.5938px\">\n<td style=\"height: 19.5938px;border-width: 0px\">Presenter:<\/td>\n<td style=\"height: 19.5938px;border-width: 0px\">Birgitte R\u00f8n\u00f8, Chief Scientific Officer at Evaxion<\/td>\n<\/tr>\n<\/table>\n<p>\n        \n      <\/p>\n<table border=\"1\" style=\"border-collapse: collapse;width: 100%;border-width: 0px;border-style: none;height: 97.969px\">\n<colgroup>\n<col style=\"width: 13.3731%\" \/>\n<col style=\"width: 86.6269%\" \/>\n        <\/colgroup>\n<tr style=\"height: 19.5938px\">\n<td style=\"height: 19.5938px;border-width: 0px\">Title:<\/td>\n<td style=\"height: 19.5938px;border-width: 0px\">AI-powered target discovery for infectious disease vaccines<\/td>\n<\/tr>\n<tr style=\"height: 19.5938px\">\n<td style=\"height: 19.5938px;border-width: 0px\">Category:<\/td>\n<td style=\"height: 19.5938px;border-width: 0px\">Emerging and re-emerging diseases<\/td>\n<\/tr>\n<tr style=\"height: 19.5938px\">\n<td style=\"height: 19.5938px;border-width: 0px\">Location:<\/td>\n<td style=\"height: 19.5938px;border-width: 0px\">Room 202b<\/td>\n<\/tr>\n<tr style=\"height: 19.5938px\">\n<td style=\"height: 19.5938px;border-width: 0px\">Date\/Time:<\/td>\n<td style=\"height: 19.5938px;border-width: 0px\">April 23, 2025, at 15.10 ET\/21.10 CET \u00a0\u00a0<\/td>\n<\/tr>\n<tr style=\"height: 19.5938px\">\n<td style=\"height: 19.5938px;border-width: 0px\">Presenter:<\/td>\n<td style=\"height: 19.5938px;border-width: 0px\">P\u00e4r Comstedt, VP, Infectious Disease Vaccine Development at Evaxion<\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">\n        \n      <\/p>\n<p align=\"justify\">\n        <b>Contact information<\/b>\u00a0<br \/>Evaxion Biotech A\/S<br \/>Mads Kronborg<br \/>Vice President, Investor Relations &amp; Communication<br \/>+45 53 54 82 96<\/p>\n<p align=\"justify\">\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NTkqXjjqBukEftXxGnawMihNVKOZRktkCKm1TCmMdHP5lh0gezLKH7uMqr6yN3OjkeO1oWdZmt7A2rBLpjCDs5P0URPgWs5HrhagjviF-ok=\" rel=\"nofollow noopener\" target=\"_blank\" data-mce-href=\"mailto:mak@evaxion.ai\">mak@evaxion.ai<\/a>\u00a0<\/p>\n<p align=\"justify\">\n        <b>About EVAXION<\/b><br \/>\n        <br \/>Evaxion Biotech A\/S is a pioneering TechBio company based upon its AI platform, AI-Immunology\u2122. Evaxion\u2019s proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Based upon AI-Immunology\u2122, Evaxion has developed a clinical-stage oncology pipeline of novel personalized vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. Evaxion is committed to transforming patients\u2019 lives by providing innovative and targeted treatment options. For more information about Evaxion and its groundbreaking AI-Immunology\u2122 platform and vaccine pipeline, please <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Y7c5cbbUVZObtcvbSiwwWJ1aPqvD1Yn0-Tocl_0b7pm3r2un2nMUe3-u1BFbkZMNPK49co3mau-89cDYtSDmHtcDQobZo1pUhdcSHGXczRQ=\" rel=\"nofollow noopener\" target=\"_blank\" data-mce-href=\"https:\/\/www.evaxion.ai\/\">visit our website<\/a>.<\/p>\n<p align=\"justify\">\n        <b>Forward-looking statement<\/b>\u00a0<br \/>This\u00a0announcement contains forward-looking statements\u00a0within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.\u00a0The words\u00a0\u201ctarget,\u201d \u201cbelieve,\u201d \u201cexpect,\u201d \u201chope,\u201d \u201caim,\u201d \u201cintend,\u201d \u201cmay,\u201d \u201cmight,\u201d \u201canticipate,\u201d \u201ccontemplate,\u201d \u201ccontinue,\u201d \u201cestimate,\u201d \u201cplan,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201cwill,\u201d \u201ccan have,\u201d \u201clikely,\u201d \u201cshould,\u201d \u201cwould,\u201d \u201ccould,\u201d and other words and terms of similar meaning\u00a0identify forward-looking statements.\u00a0Actual results may differ materially from those indicated by such forward-looking statements as a result of various factors, including, but not limited to, risks related to: our financial condition and need for additional capital; our development work; cost and success of our product development activities and preclinical and clinical trials; commercializing any approved pharmaceutical product developed using our AI platform technology, including the rate and degree of market acceptance of our product candidates; our dependence on third parties including for conduct of clinical testing and product manufacture; our inability to enter into partnerships; government regulation; protection of our intellectual property rights; employee matters and managing growth; our ADSs and ordinary shares,\u00a0the impact of international economic, political, legal, compliance, social and business factors, including inflation, and the effects on our\u00a0business from other significant geopolitical and macro-economic events;\u00a0and other uncertainties affecting our business operations and financial condition.\u00a0For a further discussion of these risks, please refer to the risk factors included in our most recent Annual Report on Form 20-F\u00a0and other filings\u00a0with the US Securities and Exchange Commission (SEC), which are available at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Xnrl9IB0KGMSEZkp1G-V8NlG3fqBPqjGdJpUXqFhG3gTJo65yAYh4NN-0QmRAQPX2NNfZOmgtO0V1SgucMsadsPCM0tfq5HO6BvXzV0veP4OPxtSQeKZwAEpbHdODgSl88R5tMTrqBmMAdOXiGKJEH1iVqOm0F6vogzdqss-toYV66pn5puVWVZeqzxxU1RduBAspWnM-lFeMMGzi1Owz0PXWEmw2FpwVU1s_Tmzt5A=\" rel=\"nofollow noopener\" target=\"_blank\" data-mce-href=\"https:\/\/www.globenewswire.com\/Tracker?data=3eX-yULjXHj_fAO4jPRASPaehYEVHM4NmXNAs_0lw5UK0DHjLXk6aKS6LI4PyMob9UvuFpZpGQrWa4b_6WQY1A==\"><b>www.sec.gov<\/b><\/a>.\u00a0We do not assume any obligation to update any forward-looking statements except as required by law.\u00a0<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA3OTQ1NCM0MDIxMTE0MjgjMjI1MjA4Nw==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/YTBmODM0YzAtZTZiYS00Mjc1LWFhZjgtMDkzNDhjYzM2NTg4LTEyNjM2NDAtMjAyNS0wNC0xMC1lbg==\/tiny\/Evaxion-Biotech.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Congress will take place April 21-24, 2025, in Washington, D.C. COPENHAGEN, Denmark, April 10, 2025 &#8211; Evaxion Biotech A\/S (NASDAQ: EVAX) (\u201cEvaxion\u201d), a clinical-stage TechBio company specializing in developing AI-Immunology\u2122 powered vaccines, will give two presentations and man a booth at the World Vaccine Congress taking place April 21-24, 2025, in Washington, D.C. Birgitte R\u00f8n\u00f8, Chief Scientific Officer at Evaxion, will talk about the application of Evaxion\u2019s AI-Immunology\u2122 platform for antigen target discovery for cancer vaccines. P\u00e4r Comstedt, Vice President, Infectious Disease Vaccine Development at Evaxion, will present the use of AI-Immunology\u2122 for target discovery for infectious disease vaccines. See details on the presentations below. The World Vaccine Congress is just one of several scientific, partnering and investor conferences where &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-to-present-at-world-vaccine-congress\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Evaxion to present at World Vaccine Congress&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-836037","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Evaxion to present at World Vaccine Congress - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-to-present-at-world-vaccine-congress\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Evaxion to present at World Vaccine Congress - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Congress will take place April 21-24, 2025, in Washington, D.C. COPENHAGEN, Denmark, April 10, 2025 &#8211; Evaxion Biotech A\/S (NASDAQ: EVAX) (\u201cEvaxion\u201d), a clinical-stage TechBio company specializing in developing AI-Immunology\u2122 powered vaccines, will give two presentations and man a booth at the World Vaccine Congress taking place April 21-24, 2025, in Washington, D.C. Birgitte R\u00f8n\u00f8, Chief Scientific Officer at Evaxion, will talk about the application of Evaxion\u2019s AI-Immunology\u2122 platform for antigen target discovery for cancer vaccines. P\u00e4r Comstedt, Vice President, Infectious Disease Vaccine Development at Evaxion, will present the use of AI-Immunology\u2122 for target discovery for infectious disease vaccines. See details on the presentations below. The World Vaccine Congress is just one of several scientific, partnering and investor conferences where &hellip; Continue reading &quot;Evaxion to present at World Vaccine Congress&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-to-present-at-world-vaccine-congress\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-10T13:14:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA3OTQ1NCM0MDIxMTE0MjgjMjI1MjA4Nw==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-to-present-at-world-vaccine-congress\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-to-present-at-world-vaccine-congress\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Evaxion to present at World Vaccine Congress\",\"datePublished\":\"2025-04-10T13:14:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-to-present-at-world-vaccine-congress\\\/\"},\"wordCount\":637,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-to-present-at-world-vaccine-congress\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA3OTQ1NCM0MDIxMTE0MjgjMjI1MjA4Nw==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-to-present-at-world-vaccine-congress\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-to-present-at-world-vaccine-congress\\\/\",\"name\":\"Evaxion to present at World Vaccine Congress - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-to-present-at-world-vaccine-congress\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-to-present-at-world-vaccine-congress\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA3OTQ1NCM0MDIxMTE0MjgjMjI1MjA4Nw==\",\"datePublished\":\"2025-04-10T13:14:19+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-to-present-at-world-vaccine-congress\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-to-present-at-world-vaccine-congress\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-to-present-at-world-vaccine-congress\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA3OTQ1NCM0MDIxMTE0MjgjMjI1MjA4Nw==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA3OTQ1NCM0MDIxMTE0MjgjMjI1MjA4Nw==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evaxion-to-present-at-world-vaccine-congress\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Evaxion to present at World Vaccine Congress\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Evaxion to present at World Vaccine Congress - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-to-present-at-world-vaccine-congress\/","og_locale":"en_US","og_type":"article","og_title":"Evaxion to present at World Vaccine Congress - Market Newsdesk","og_description":"Congress will take place April 21-24, 2025, in Washington, D.C. COPENHAGEN, Denmark, April 10, 2025 &#8211; Evaxion Biotech A\/S (NASDAQ: EVAX) (\u201cEvaxion\u201d), a clinical-stage TechBio company specializing in developing AI-Immunology\u2122 powered vaccines, will give two presentations and man a booth at the World Vaccine Congress taking place April 21-24, 2025, in Washington, D.C. Birgitte R\u00f8n\u00f8, Chief Scientific Officer at Evaxion, will talk about the application of Evaxion\u2019s AI-Immunology\u2122 platform for antigen target discovery for cancer vaccines. P\u00e4r Comstedt, Vice President, Infectious Disease Vaccine Development at Evaxion, will present the use of AI-Immunology\u2122 for target discovery for infectious disease vaccines. See details on the presentations below. The World Vaccine Congress is just one of several scientific, partnering and investor conferences where &hellip; Continue reading \"Evaxion to present at World Vaccine Congress\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-to-present-at-world-vaccine-congress\/","og_site_name":"Market Newsdesk","article_published_time":"2025-04-10T13:14:19+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA3OTQ1NCM0MDIxMTE0MjgjMjI1MjA4Nw==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-to-present-at-world-vaccine-congress\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-to-present-at-world-vaccine-congress\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Evaxion to present at World Vaccine Congress","datePublished":"2025-04-10T13:14:19+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-to-present-at-world-vaccine-congress\/"},"wordCount":637,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-to-present-at-world-vaccine-congress\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA3OTQ1NCM0MDIxMTE0MjgjMjI1MjA4Nw==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-to-present-at-world-vaccine-congress\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-to-present-at-world-vaccine-congress\/","name":"Evaxion to present at World Vaccine Congress - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-to-present-at-world-vaccine-congress\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-to-present-at-world-vaccine-congress\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA3OTQ1NCM0MDIxMTE0MjgjMjI1MjA4Nw==","datePublished":"2025-04-10T13:14:19+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-to-present-at-world-vaccine-congress\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-to-present-at-world-vaccine-congress\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-to-present-at-world-vaccine-congress\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA3OTQ1NCM0MDIxMTE0MjgjMjI1MjA4Nw==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA3OTQ1NCM0MDIxMTE0MjgjMjI1MjA4Nw=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evaxion-to-present-at-world-vaccine-congress\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Evaxion to present at World Vaccine Congress"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/836037","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=836037"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/836037\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=836037"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=836037"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=836037"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}